Publications by authors named "C Pomari"
Background: Public health measures for COVID-19 mitigation influenced the circulation of Respiratory Syncytial Virus (RSV) during the 2020-2021 winter season. In the following autumn, an unprecedented resurgence of RSV occurred. Our study monitored RSV pediatric infections one and two years after the relaxation of containment measures for the COVID-19 pandemic.
View Article and Find Full Text PDFArticle Synopsis
- Optimal treatment for metastatic non-small cell lung cancer (NSCLC) with mesenchymal epithelial transition gene (MET) exon 14 skipping mutation is still being researched, but MET inhibitors like tepotinib show promise.
- A case study of an 86-year-old male with this mutation demonstrated a partial response to tepotinib as first-line treatment, though he experienced manageable side effects like peripheral edema.
- The patient has maintained an ongoing positive response to tepotinib for 31 months, suggesting it could be a beneficial option for older patients with similar conditions, even when high PD-L1 expression is present.
We performed a follow-up of a previously reported SARS-CoV-2 prevalence study (April‒May 2020) in Verona, Italy. Through May 2022, only <1.1% of the city population had never been infected or vaccinated; 8.
View Article and Find Full Text PDFWe used random sampling to estimate the prevalence of severe acute respiratory syndrome coronavirus 2 infection in Verona, Italy. Of 1,515 participants, 2.6% tested positive by serologic assay and 0.
View Article and Find Full Text PDFIntroduction: As of 30 April 2020, the novel betacoronavirus SARS-CoV-2 had infected more than 3 172 000 individuals, killing over 224 000 people and spreading to more than 200 countries. Italy was the most affected country in Europe and the third most affected in the world in terms of the number of cases. Therefore, the aims of this study are: (1) to estimate the prevalence of asymptomatic SARS-CoV-2-positive individuals among the general population of Verona; (2) to assess the accuracy (sensitivity, specificity and predictive values) of an ELISA serological test for the screening of SARS-CoV-2.
View Article and Find Full Text PDF